Recent studies have shown that early intervention at pre-diabetic state and beta-cell protection with insulin sensitizers may improve the prognosis of diabetes.[1, 2] Any new oral hypoglycemic drug that can improve the control of blood sugar with fewer adverse effects may be welcomed. The gene discussed is INS; the disease is diabetes mellitus.